FABBRI, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 51.474
EU - Europa 21.739
AS - Asia 21.392
SA - Sud America 2.366
AF - Africa 415
OC - Oceania 114
Continente sconosciuto - Info sul continente non disponibili 45
Totale 97.545
Nazione #
US - Stati Uniti d'America 50.996
GB - Regno Unito 8.152
CN - Cina 6.851
SG - Singapore 6.460
IT - Italia 3.760
HK - Hong Kong 2.812
SE - Svezia 1.877
FI - Finlandia 1.856
BR - Brasile 1.834
DE - Germania 1.613
VN - Vietnam 1.594
UA - Ucraina 1.405
TR - Turchia 1.068
FR - Francia 798
RU - Federazione Russa 778
KR - Corea 669
BG - Bulgaria 510
IN - India 385
ID - Indonesia 261
BD - Bangladesh 249
CA - Canada 235
NL - Olanda 202
AR - Argentina 181
IQ - Iraq 177
IE - Irlanda 176
MX - Messico 153
JP - Giappone 130
PK - Pakistan 115
ZA - Sudafrica 108
AU - Australia 103
PL - Polonia 91
CO - Colombia 71
CL - Cile 67
AE - Emirati Arabi Uniti 66
BE - Belgio 65
RO - Romania 63
ES - Italia 62
EC - Ecuador 61
AT - Austria 56
MY - Malesia 51
EG - Egitto 50
VE - Venezuela 48
PH - Filippine 47
SA - Arabia Saudita 47
TH - Thailandia 47
MA - Marocco 46
UZ - Uzbekistan 45
IR - Iran 39
NP - Nepal 38
TN - Tunisia 38
EU - Europa 36
PY - Paraguay 36
CH - Svizzera 35
JO - Giordania 31
PT - Portogallo 31
NG - Nigeria 28
KE - Kenya 27
TW - Taiwan 27
PE - Perù 26
UY - Uruguay 25
AZ - Azerbaigian 23
CZ - Repubblica Ceca 23
AL - Albania 22
OM - Oman 22
RS - Serbia 21
DZ - Algeria 20
SI - Slovenia 20
BY - Bielorussia 19
IL - Israele 18
LT - Lituania 18
CR - Costa Rica 17
BO - Bolivia 16
ET - Etiopia 16
BH - Bahrain 14
DK - Danimarca 14
LB - Libano 14
KZ - Kazakistan 13
SY - Repubblica araba siriana 13
AO - Angola 12
HN - Honduras 12
KG - Kirghizistan 12
SN - Senegal 12
HR - Croazia 11
DO - Repubblica Dominicana 10
JM - Giamaica 10
LV - Lettonia 9
PA - Panama 9
GE - Georgia 8
HU - Ungheria 8
NI - Nicaragua 8
QA - Qatar 8
CI - Costa d'Avorio 7
EE - Estonia 7
MD - Moldavia 7
NZ - Nuova Zelanda 7
GR - Grecia 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
CY - Cipro 5
Totale 97.416
Città #
Southend 6.009
Fairfield 5.795
Woodbridge 4.243
Ashburn 4.197
Singapore 4.159
Jacksonville 3.091
Houston 3.087
Santa Clara 2.980
Hefei 2.808
Hong Kong 2.761
Chandler 2.262
Seattle 2.082
Dearborn 1.993
Wilmington 1.986
Cambridge 1.900
Ann Arbor 1.870
San Jose 1.491
Helsinki 1.353
London 1.290
Beijing 1.074
Nyköping 900
The Dalles 784
Chicago 721
Modena 677
Seoul 637
Los Angeles 613
San Diego 585
Princeton 556
Izmir 503
Sofia 499
Des Moines 495
Council Bluffs 492
Eugene 484
Ho Chi Minh City 478
Hanoi 400
Lauterbourg 397
Milan 340
New York 322
Salt Lake City 292
Buffalo 284
Rome 253
Moscow 222
Dallas 195
Columbus 177
Shanghai 177
Dublin 172
São Paulo 166
Tampa 148
Elk Grove Village 128
Frankfurt am Main 121
Jakarta 118
Redwood City 117
Falls Church 116
Guangzhou 97
Norwalk 96
Tokyo 94
Boardman 88
Da Nang 86
Nanjing 84
Kent 83
Palermo 81
Grafing 77
Warsaw 74
Sterling 72
Haiphong 65
Baghdad 64
Kunming 61
Lancaster 59
Atlanta 58
Brooklyn 57
Falkenstein 56
Orem 56
San Francisco 56
Amsterdam 55
Chennai 55
Phoenix 54
Naples 52
Mexico City 48
Jinan 47
Mumbai 47
Verona 46
Kilburn 45
Miami 45
Bari 44
Philadelphia 44
Rio de Janeiro 44
Wuhan 44
Brussels 42
Jersey City 42
Boston 41
Detroit 41
Munich 40
Belo Horizonte 39
Bologna 39
Curitiba 39
Washington 39
Dhaka 38
Florence 38
Melbourne 38
Chengdu 37
Totale 71.647
Nome #
Medicina Interna Sistematica 2.071
Asma bronchiale 655
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 477
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 474
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 449
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 431
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary 410
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 404
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 394
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 378
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 377
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 358
Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 352
Effects of a walking aid in COPD patients receiving oxygen therapy 351
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 350
Chronic Lung Disease in HIV Patients 337
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFR alpha, PDGFR beta, and met in large-cell neuroendocrine carcinoma of the lung 335
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 331
Update in Chronic Obstructive Pulmonary Disease 2005 327
La broncopneumopatia cronica ostruttiva nell'anziano 327
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 316
Update in chronic obstructive pulmonary disease 2006 314
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 313
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 313
Treatment of chronic obstructive pulmonary disease and its comorbidities 313
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 312
Cellular and structural bases of chronic obstructive pulmonary disease 308
From COPD to chronic systemic inflammatory syndrome? 308
Roflumilast:un nuovo farmaco per il trattamento della BPCO 307
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 307
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 307
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial 306
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial 304
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma 303
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 302
Complex chronic co-morbidities of COPD 301
Breakthroughs in internal and respiratory medicine 301
Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States 301
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 299
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 299
Insufficienza Respiratoria acuta e cronica (cap.21). 297
Prognostic role of clusterin in resected adenocarcinomas of the lung. 296
Chronic critical illness: the price of survival 295
Inhaled Corticosteroids in COPD: Pros and Cons. 294
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 294
Clusterin (CLU) and lung cancer 288
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: Two randomised clinical trials 283
Benralizumab: for asthma, not yet for COPD 281
How to Integrate Multiple Comorbidities in Guideline Development 278
Macrolides in the treatment of asthma and cystic fibrosis 278
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 277
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 275
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 272
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 269
Early diagnosis of subclinical multi drug-resistant tuberculosis 268
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 268
Mechanisms of bradykinin-induced contraction in human fetal lung fibroblasts. 267
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 266
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma 265
Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals. 265
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 264
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. 264
Tiotropium versus salmeterol for the prevention of exacerbations of COPD 262
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies 261
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. 261
Pathophysiology of exacerbations of chronic obstructive pulmonary disease 260
Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate 258
Eosinophilia in asthma: the easy way is not always the best 258
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa 257
Sarcoidosis: challenging diagnostic aspects of an old disease. 256
Asthma in the elderly: what we know and what we have yet to know 255
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. 253
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 253
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 253
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 252
Blood tests for diagnosis of tuberculosis - Reply 250
The pharmacoepidemiology of COPD: recent advances and methodological discussion. 248
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial 246
Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction. 246
Airway eosinophilia in chronic bronchitis during exacerbations. 246
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 246
Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing 245
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials 245
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy 244
Home-centred physical fitness programme in morbidly obese individuals: a randomized controlled trial 244
Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma 242
Chronic disease in the elderly: back to the future of internal medicine. 241
Effect of antiasthma drugs on asthmatic reactions induced by toluene diisocyanate in sensitized subjects. 241
Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. 241
Significant chronic airway abnormalities in never-smoking HIV-infected patients 241
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. 240
Airway inflammation in occupational asthma. 239
Smoking, Not COPD, as the Disease 239
Effects of early inpatient rehabilitation after acute exacerbation of COPD 237
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 237
An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease 235
Intrapulmonary percussive ventilation in tracheostomized patients: A randomized controlled trial 234
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma 234
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum. 233
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 232
Totale 31.191
Categoria #
all - tutte 377.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 377.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.105 0 0 0 0 0 0 0 0 0 1.140 499 466
2021/20228.366 186 1.276 963 673 216 357 636 409 851 561 1.330 908
2022/20236.892 803 496 362 556 845 1.260 116 733 1.035 118 316 252
2023/20244.221 176 311 297 440 772 440 423 530 148 122 143 419
2024/202514.078 611 264 175 868 2.559 1.611 887 778 1.851 905 1.727 1.842
2025/202625.233 1.693 1.357 3.209 2.727 3.304 2.789 4.155 1.475 2.387 2.137 0 0
Totale 98.016